Latest Roche Group Stories
Company's two-booth approach allows customers to see how Roche is partnering with them today and tomorrow CHICAGO, July 29, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) launched
LAVAL, QC, June 10, 2014 /CNW Telbec/ - Roche announced that Health Canada approved the cobas® 4800 HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical
Formation of strategic alliance designed to help accelerate advancement of new methods in molecular diagnostics testing and personalized predictive treatment
CHICAGO, April 29, 2014 /PRNewswire/ -- Roche Diagnostics has selected HY Connect, an independent, full-service
Expanded indication makes cobas® HPV Test the only test approved in U.S.
TUCSON, Ariz., March 27, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc.
PLEASANTON, Calif., March 12, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S.
TUCSON, March 11, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc.
TUCSON, Ariz., March 5, 2014 /PRNewswire/ -- An international panel of leaders in the pathology community today announced its support of four principles designed to drive positive change and improve
TUCSON, Ariz., Feb. 25, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc.